AXA (OTCMKTS:AXAHY) Rating Lowered to Sell at Zacks Investment Research

AXA (OTCMKTS:AXAHY) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research report issued on Monday, Zacks.com reports.

According to Zacks, “The AXA Group is an international group of insurance and related financial services companies. AXA’s insurance operations are diverse geographically, with activities in 50 countries, principally Western Europe, North America and the Asia/Pacific area. In the United States, AXA is represented through its 60% holding in The Equitable companies and its subsidiaries, Equitable Life, Alliance Capital management and Donaldson, Lufkin & Jenrette. “

A number of other research firms also recently commented on AXAHY. Barclays upgraded AXA from an “equal weight” rating to an “overweight” rating in a research note on Wednesday, December 4th. ValuEngine downgraded AXA from a “hold” rating to a “sell” rating in a research note on Wednesday, November 6th.

OTCMKTS:AXAHY traded up $0.14 during mid-day trading on Monday, reaching $28.12. The stock had a trading volume of 142,638 shares, compared to its average volume of 110,161. The company has a market capitalization of $67.91 billion, a price-to-earnings ratio of 9.22, a price-to-earnings-growth ratio of 1.70 and a beta of 1.07. AXA has a 1-year low of $22.27 and a 1-year high of $28.49. The stock’s 50 day simple moving average is $27.70 and its two-hundred day simple moving average is $26.10.

AXA Company Profile

AXA SA, through its subsidiaries, provides insurance and asset management services worldwide. It operates in seven segments: France, Europe, Asia, AXA XL, the United States, International, and Transversal & Central Holdings. The company offers a range of insurance products, including life and savings, property and casualty, and health.

Read More: How to execute a trade ex-dividend strategy?

Get a free copy of the Zacks research report on AXA (AXAHY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for AXA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AXA and related companies with MarketBeat.com's FREE daily email newsletter.